China BlueChemical (CBLUY)
(Delayed Data from OTC)
$11.19 USD
0 (0.00%)
Updated Dec 31, 1969 06:00 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for China BlueChemical Ltd falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 1,865 | 1,865 | 1,743 | 1,508 | 1,263 |
Receivables | 69 | 87 | 100 | 92 | 94 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 138 | 177 | 191 | 145 | 161 |
Other Current Assets | 129 | 172 | 53 | 93 | 57 |
Total Current Assets | 2,201 | 2,301 | 2,087 | 1,838 | 1,575 |
Net Property & Equipment | 1,009 | 1,046 | 1,045 | 947 | 977 |
Investments & Advances | 69 | 59 | 64 | 51 | 79 |
Other Non-Current Assets | 29 | 0 | 0 | 0 | 0 |
Deferred Charges | 22 | 8 | 6 | 68 | 73 |
Intangibles | 40 | 24 | 26 | 23 | 23 |
Deposits & Other Assets | 66 | 54 | 94 | 79 | 83 |
Total Assets | 3,436 | 3,492 | 3,322 | 3,006 | 2,810 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 161 | 200 | 207 | 107 | 100 |
Current Portion Long-Term Debt | 92 | 129 | 69 | 281 | 230 |
Current Portion Capital Leases | 1 | 3 | 1 | 1 | 1 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 13 | 19 | 27 | 11 | 5 |
Other Current Liabilities | 177 | 259 | 229 | 310 | 191 |
Total Current Liabilities | 444 | 610 | 534 | 710 | 526 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 21 | 19 | 24 | 20 | 22 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 191 | 176 | 89 | 1 | 61 |
Non-Current Capital Leases | 1 | 1 | 3 | 3 | 3 |
Other Non-Current Liabilities | 37 | 45 | 52 | 7 | 10 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 694 | 850 | 700 | 742 | 623 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 651 | 685 | 715 | 668 | 667 |
Capital Surplus | 157 | 165 | 172 | 161 | 161 |
Retained Earnings | 1,347 | 1,237 | 1,170 | 1,027 | 979 |
Other Equity | 587 | 555 | 565 | 408 | 381 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 2,742 | 2,642 | 2,622 | 2,265 | 2,187 |
Total Liabilities & Shareholder's Equity | 3,436 | 3,492 | 3,322 | 3,006 | 2,810 |
Total Common Equity | 2,742 | 2,642 | 2,622 | 2,265 | 2,187 |
Shares Outstanding | 92.20 | 92.20 | 92.20 | 92.20 | 92.20 |
Book Value Per Share | 29.74 | 28.65 | 28.44 | 24.56 | 23.72 |
Fiscal Year End for China BlueChemical Ltd falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 1,828 | -99,999 | 1,865 | -99,999 | 1,729 |
Receivables | 56 | NA | 69 | NA | 60 |
Notes Receivable | NA | NA | 0 | NA | NA |
Inventories | 141 | NA | 138 | NA | 192 |
Other Current Assets | 122 | NA | 129 | NA | 101 |
Total Current Assets | 2,147 | NA | 2,201 | NA | 2,081 |
Net Property & Equipment | 974 | NA | 1,009 | NA | 1,011 |
Investments & Advances | 67 | NA | 69 | NA | 67 |
Other Non-Current Assets | 29 | NA | 29 | NA | 109 |
Deferred Charges | 22 | NA | 22 | NA | 20 |
Intangibles | 37 | NA | 40 | NA | 29 |
Deposits & Other Assets | 56 | NA | 66 | NA | 61 |
Total Assets | 3,331 | NA | 3,436 | NA | 3,379 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | NA | 0 | NA | NA |
Accounts Payable | 153 | NA | 161 | NA | 168 |
Current Portion Long-Term Debt | 77 | NA | 92 | NA | 82 |
Current Portion Capital Leases | 4 | NA | 1 | NA | 1 |
Accrued Expenses | NA | NA | 0 | NA | NA |
Income Taxes Payable | 12 | NA | 13 | NA | 12 |
Other Current Liabilities | 162 | NA | 177 | NA | 177 |
Total Current Liabilities | 408 | NA | 444 | NA | 440 |
Mortgages | NA | NA | 0 | NA | NA |
Deferred Taxes/Income | 20 | NA | 21 | NA | 18 |
Convertible Debt | NA | NA | 0 | NA | NA |
Long-Term Debt | 226 | NA | 191 | NA | 204 |
Non-Current Capital Leases | 5 | NA | 1 | NA | 1 |
Other Non-Current Liabilities | 33 | 37 | NA | 40 | |
Minority Interest (Liabilities) | NA | NA | 0 | NA | NA |
Total Liabilities | 693 | NA | 694 | NA | 702 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | NA | 0 | NA | NA |
Common Stock (Par) | 637 | NA | 651 | NA | 657 |
Capital Surplus | NA | NA | 157 | NA | 158 |
Retained Earnings | NA | NA | 1,347 | NA | 1,428 |
Other Equity | 2,002 | NA | 587 | NA | 433 |
Treasury Stock | NA | NA | 0 | NA | NA |
Total Shareholder's Equity | 2,638 | NA | 2,742 | NA | 2,677 |
Total Liabilities & Shareholder's Equity | 3,331 | NA | 3,436 | NA | 3,379 |
Total Common Equity | 102,637 | 0 | 2,742 | 0 | 102,676 |
Shares Outstanding | 92.20 | 92.20 | 92.20 | 92.20 | 92.20 |
Book Value Per Share | 1,113.20 | 0.00 | 29.74 | 0.00 | 1,113.62 |